Per Artursson

Uppsala University — Sweden

Medicine · Health Sciences

94h-index30.6kcitations373works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Transport and Resistance Mechanisms(122), Drug Solubulity and Delivery Systems(48), Advanced Drug Delivery Systems(46), Pharmacological Effects and Toxicity Studies(42), Pharmacogenetics and Drug Metabolism(41)

Publications373 total

Maturation of human intestinal epithelial cell layers fortifies the apical surface against Salmonella attack
Cell Reports·2025· 2 citedOpen Access
The intracellular free concentration of endocrine disrupting chemicals enables translation between cell-free and cell-based estrogenic activity assays
Environmental Toxicology and Pharmacology·2025· 1 citedOpen Access
Global proteomic profiling of a patient-derived 3D CYST model and reference tissue of polycystic kidney disease
Drug Metabolism and Pharmacokinetics·2025
Identification of drug target engagement of repurposing candidates for polycystic kidney disease by thermal proteome profiling
Drug Metabolism and Pharmacokinetics·2025
A Patient‐Derived <scp>3D</scp> Cyst Model of Polycystic Kidney Disease That Mimics Disease Development and Responds to Repurposing Candidates
Clinical and Translational Science·2025· 1 citedOpen Access
Human jejunal enteroids for studies of epithelial drug transport and metabolism
2025Open Access
Mild-to-moderate psoriasis is associated with subclinical inflammation in the duodenum and a tendency of disturbed intestinal barrier
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease·2024· 4 citedOpen Access
Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib
EBioMedicine·2024· 7 citedOpen Access
Global 13C tracing and metabolic flux analysis of intact human liver tissue ex vivo
Nature Metabolism·2024· 13 citedOpen Access
Proteomic Profiling Reveals Age-Related Changes in Transporter Proteins in the Human Blood-Brain Barrier
2024· 3 citedOpen Access
Maturation of Human Intestinal Epithelial Cell Layers Fortifies the Apical Surface against <i>Salmonella</i> Attack
2024· 1 citedOpen Access
Illuminating the function of the orphan transporter, SLC22A10, in humans and other primates
Nature Communications·2024· 4 citedOpen Access
In vitro models to determine human intestinal presystemic metabolism after oral dosing
Drug Metabolism and Pharmacokinetics·2024Open Access
Expression of intestinal drug transporter proteins and metabolic enzymes in neonatal and pediatric patients
International Journal of Pharmaceutics·2024· 2 citedOpen Access
The choice of ultra‐low attachment plates impacts primary human and primary canine hepatocyte spheroid formation, phenotypes, and function
Biotechnology Journal·2024· 20 citedOpen Access
Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight Individuals
Clinical Pharmacokinetics·2023· 7 citedOpen Access
Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
2023· 1 citedOpen Access
Loss of CYP2D6 sensitizes hepatocellular carcinomas and neuroblastomas to talazoparib
2023Open Access
Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
2023Open Access
Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance
Clinical Pharmacokinetics·2023· 4 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

Kristina Luthman(9), Katrin Palm(7), Johan Karlsson(6), Ulf Norinder(6), Christel A. S. Bergström(6), Kjell M. Vårum(5), Anna‐Lena Ungell(5), Tuulikki Lindmark(4), Patric Stenberg(4), Eva Ragnarsson(3), Alex Avdeef(3), Nicolaas Schipper(3), Constanze Hilgendorf(3), Magnus Köping‐Höggård(3), Lucia Lazorova(3), Pär Matsson(3), Gustav Ahlin(2), KM Vårum(2), Tobias Koolmeister(2), Ann‐Sofie Jemth(2)